Picard Medical, Inc. (PMI)
XASE:PMI
Want to see PMI full AI Analyst Report?
PMI Stock Chart & Stats
$1.82
--
Market closed
$1.82
--
Day’s Range― - ―
52-Week Range$0.40 - $13.68
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.38M
Market Cap
N/A
Enterprise Value$738.34M
Total Cash (Recent Filing)$7.45M
Total Debt (Recent Filing)$6.97M
Price to Earnings (P/E)―
Beta-0.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding75,178,535
10 Day Avg. Volume2,124,305
30 Day Avg. Volume2,378,935
Financial Highlights & Ratios
PEG Ratio-0.39
Price to Book (P/B)34.04
Price to Sales (P/S)26.11
P/FCF Ratio-8.23
Enterprise Value/Market Cap10.00T>
Enterprise Value/Revenue149.25
Enterprise Value/Gross Profit3.69K
Enterprise Value/Ebitda-37.95
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proven SynCardia Clinical Track RecordA demonstrated long-term implant record and multi-year patient support show the SynCardia system works as a durable bridge-to-transplant. Clinical longevity and real-world durability underpin adoption at transplant centers and reinforce a sustainable core revenue base for advanced heart-failure care.
Pipeline Innovation — Emperor ProgramActive development of a fully implantable, autoregulating artificial heart represents a structural product upgrade that could expand indications and address mobility limits of current controllers. If successful, this extension strengthens competitive moat and long-term growth potential in MCS.
Improving Balance Sheet TrajectoryA move from negative to positive equity and lower debt improves solvency and investor confidence. This trajectory increases ability to secure non-dilutive financing, negotiate supplier terms, and execute clinical/commercial plans over months, reducing near-term capital structure fragility.
Bears Say
High And Worsening Cash BurnSustained negative operating and free cash flow, with cash burn accelerating, forces repeated capital raises and constrains strategic flexibility. Over 2–6 months, ongoing outflows make execution on R&D, commercialization, and regulatory milestones contingent on external funding availability.
Deep Ongoing LossesExtremely negative net margins and only marginal gross margin recovery mean the core business is not yet generating sustainable profits. Without significant margin expansion or rapid revenue scale, the company will remain dependent on funding, limiting reinvestment and shareholder returns.
Dilutive, Restrictive Financing RiskReliance on short-term private notes with high fees, punitive default conversion and restrictions on dividends increases dilution and gives counterparties control levers. Structurally, this raises governance and capital-return risk and can impair long-term equity value if operational targets slip.
Picard Medical, Inc. News
PMI FAQ
What was Picard Medical, Inc.’s price range in the past 12 months?
Picard Medical, Inc. lowest stock price was $0.40 and its highest was $13.68 in the past 12 months.
What is Picard Medical, Inc.’s market cap?
Currently, no data Available
When is Picard Medical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Picard Medical, Inc.’s earnings last quarter?
Currently, no data Available
Is Picard Medical, Inc. overvalued?
According to Wall Street analysts Picard Medical, Inc.’s price is currently Overvalued.
Does Picard Medical, Inc. pay dividends?
Picard Medical, Inc. does not currently pay dividends.
What is Picard Medical, Inc.’s EPS estimate?
Picard Medical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Picard Medical, Inc. have?
Picard Medical, Inc. has 75,178,535 shares outstanding.
What happened to Picard Medical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Picard Medical, Inc.?
Currently, no hedge funds are holding shares in PMI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Picard Medical, Inc.
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc
PMI Company Deck
PMI Earnings Call
Q4 2026
0:00 / 0:00
Technical Analysis
Aethlon Medical
―
―
Catheter Precision
―
Heart Test Laboratories, Inc.
―
Autonomix Medical, Inc.
―
Ownership Overview
―
Insiders
0.13% Mutual Funds
0.06% Other Institutional Investors
99.75% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---